Osteoarthritis candidate MM-II shows durable pain relief in global phase 2b study: Sun Pharma Ruchika Sharma23 March 2023 5:56 AM GMTOsteoarthritis is one of the most common chronic health conditions and a leading cause of pain and disability among adults.
Concert Pharma Deuruxolitinib significantly improves scalp hair regrowth in Alopecia areata, reveals data Ruchika Sharma21 March 2023 7:45 AM GMTDeuruxolitinib is an investigational oral selective inhibitor of Janus kinases JAK1 and JAK2.
Sun Pharma concludes acquisition of Concert Pharma Ruchika Sharma7 March 2023 9:00 AM GMTAcquisition adds Deuruxolitinib for the treatment of alopecia areata, to Sun Pharma’s global dermatology portfolio
Information security incident occurred at Sun Pharma, impacted IT assets isolated Ruchika Sharma3 March 2023 7:00 AM GMTNew Delhi: Drug major Sun Pharma has reported an "information security incident" at the company and said it is investigating the matter. The...
Health Bulletin 1/March/2023 Payodhi Chaturvedi1 March 2023 10:48 AM GMTHere are the top health stories for the day:Proposed: NMC to conduct NEET UG examThe National Medical Commission (NMC), the apex medical regulator of...
CDSCO panel nod to Sun Pharma to manufacture, market antidiabetic FDC drug Dr. Nandita Mohan26 Feb 2023 9:59 AM GMTIn a significant development, pharmaceutical major, Sun Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the...
Health Bulletin 25/February/2023 Dr. Nandita Mohan25 Feb 2023 10:53 AM GMTHere are the top health stories for the day:Supreme Court hearing on NEET PG 2023 postponed to continue on MondayThe Supreme Court has deferred the...
Sun Pharma plea against NPPA price fixation for Acetazolamide IP 500 mg rejected Farhat Nasim20 Feb 2023 12:30 PM GMTNew Delhi: Upholding the retail price fixed by the National Pharmaceutical Pricing Authority (NPPA), the Department of Pharmaceuticals (DoP) has...
Sun Pharma acquires DCGI approved anti-inflammatory brand Phlogam from Aksigen Hospital Care Dr. Nandita Mohan20 Feb 2023 5:35 AM GMTPhlogam administered orally, offers systemic enzyme-flavonoid therapy
Sun Pharma Acquires Anti-inflammatory brand Phlogam from Aksigen Hospital Care Ruchika Sharma14 Feb 2023 10:16 AM GMTPhlogam administered orally, offers systemic enzyme-flavonoid therapy.
Sun Pharma recalls over 34000 bottles of generic medication in US due to failed dissolution testing Ruchika Sharma11 Feb 2023 9:05 AM GMTNew Delhi: Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to...
Sun Pharma bags USFDA okay for generic lenalidomide capsules Ruchika Sharma11 Feb 2023 7:00 AM GMTMumbai: Pharma major, Sun Pharmaceutical Industries Limited, has announced that one of its wholly owned subsidiaries has received final approval from...
